These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 14696090)
21. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites. Soler C; Alvarez CV; Beguinot L; Carpenter G Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006 [TBL] [Abstract][Full Text] [Related]
22. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway. Xie H; Pallero MA; Gupta K; Chang P; Ware MF; Witke W; Kwiatkowski DJ; Lauffenburger DA; Murphy-Ullrich JE; Wells A J Cell Sci; 1998 Mar; 111 ( Pt 5)():615-24. PubMed ID: 9454735 [TBL] [Abstract][Full Text] [Related]
23. EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation. Kim SE; Choi KY Cell Signal; 2007 Jul; 19(7):1554-64. PubMed ID: 17374561 [TBL] [Abstract][Full Text] [Related]
24. Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway. Tan X; Egami H; Abe M; Nozawa F; Hirota M; Ogawa M J Clin Pathol; 2005 Dec; 58(12):1242-8. PubMed ID: 16311341 [TBL] [Abstract][Full Text] [Related]
25. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells. Zhong H; Minneman KP Biochem J; 1999 Dec; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878 [TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446 [TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. Chen P; Xie H; Sekar MC; Gupta K; Wells A J Cell Biol; 1994 Nov; 127(3):847-57. PubMed ID: 7962064 [TBL] [Abstract][Full Text] [Related]
28. Analysis of the epidermal growth factor receptor specific transcriptome: effect of receptor expression level and an activating mutation. Pedersen MW; Pedersen N; Damstrup L; Villingshøj M; Sønder SU; Rieneck K; Bovin LF; Spang-Thomsen M; Poulsen HS J Cell Biochem; 2005 Oct; 96(2):412-27. PubMed ID: 16075456 [TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Gschwind A; Prenzel N; Ullrich A Cancer Res; 2002 Nov; 62(21):6329-36. PubMed ID: 12414665 [TBL] [Abstract][Full Text] [Related]
30. Antagonistic and agonistic effects of quinazoline tyrosine kinase inhibitors on mutant EGF receptor function. Montgomery RB Int J Cancer; 2002 Sep; 101(2):111-7. PubMed ID: 12209987 [TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. Chakravarti A; Loeffler JS; Dyson NJ Cancer Res; 2002 Jan; 62(1):200-7. PubMed ID: 11782378 [TBL] [Abstract][Full Text] [Related]
32. Dissociation of focal adhesion kinase and paxillin tyrosine phosphorylation induced by bombesin and lysophosphatidic acid from epidermal growth factor receptor transactivation in Swiss 3T3 cells. Salazar EP; Hunger-Glaser I; Rozengurt E J Cell Physiol; 2003 Mar; 194(3):314-24. PubMed ID: 12548551 [TBL] [Abstract][Full Text] [Related]